1887

Abstract

Determination of the avidity of specific IgG antibodies has become a generally accepted diagnostic aid for dating infection. In this study, the Labsystems, VIDAS and EUROIMMUN IgG avidity assays were compared on a series of 133 IgG- and IgM-positive sera from symptomatic patients (=28), from pregnant (=43) and non-pregnant (=26) women, and on 18 IgG-positive and IgM-negative sera from chronically infected patients. The results showed excellent concordance between the Labsystems and VIDAS tests in both the IgM-positive (=0.82, =0.771) and IgM-negative (=0.609) sera, whilst the agreement of the EUROIMMUN assay with both the Labsystems and VIDAS tests in the IgM-positive sera was moderate (=0.575 and =0.525, respectively) and in the IgM-negative sera was poor (=0.000). Analysis of the kinetics of the maturation of avidity in 13 patients in whom follow-up sera were available showed that, despite a general trend of maturation, in two patients the avidity did not become high during 6 and 11 months of follow-up. In view of the clinical setting, in the symptomatic patients, despite one case of complete discrepancy and five cases of partial discrepancy, the Labsystems and VIDAS tests were in almost perfect agreement (=0.812), whilst the agreement in pregnant and non-pregnant women was substantial (=0.754 and =0.708, respectively). In conclusion, the Labsystems and VIDAS tests are equally reliable for the measurement of IgG avidity; the choice of test should depend on the laboratory set-up. The EUROIMMUN test may be an acceptable alternative in resource-limited settings, but should be used prudently.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.006668-0
2009-03-01
2019-11-19
Loading full text...

Full text loading...

/deliver/fulltext/jmm/58/3/358.html?itemId=/content/journal/jmm/10.1099/jmm.0.006668-0&mimeType=html&fmt=ahah

References

  1. Alvarado-Esquivel, C., Sethi, S., Janitschke, K., Hahn, H. & Liesenfeld, O. ( 2002; ). Comparison of two commercially available avidity tests for Toxoplasma-specific IgG antibodies. Arch Med Res 33, 520–523.[CrossRef]
    [Google Scholar]
  2. Barberi, A., Gistri, A., Cappelletti, F. & Giordano, I. ( 2001; ). Diagnostic value of IgG avidity in Toxoplasma infection: comparison of 3 commercial kits. J Infect Dis 184, 944–946.
    [Google Scholar]
  3. Bobić, B., Šibalić, D. & Djurković-Djaković, O. ( 1991; ). High levels of IgM antibodies specific for Toxoplasma gondii in pregnancy 12 years after primary toxoplasma infection. Gynecol Obstet Invest 31, 182–184.[CrossRef]
    [Google Scholar]
  4. Brown, S. E., Howard, C. R., Zuckerman, A. J. & Steward, M. W. ( 1984; ). Affinity of antibody responses in man to hepatitis B vaccine determined with synthetic peptides. Lancet 2, 184–187.
    [Google Scholar]
  5. Desmonts, G. & Remington, J. S. ( 1980; ). Direct agglutination test for diagnosis of Toxoplasma infection: method for increasing sensitivity and specificity. J Clin Microbiol 11, 562–568.
    [Google Scholar]
  6. Flori, P., Tardy, L., Patural, H., Bellete, B., Varlet, M. N., Hafid, J., Raberin, H. & Sung, R. T. ( 2004; ). Reliability of immunoglobulin G antitoxoplasma avidity test and effects of treatment on avidity indexes of infants and pregnant women. Clin Diagn Lab Immunol 11, 669–674.
    [Google Scholar]
  7. Flori, P., Bellete, B., Crampe, C., Maudry, A., Patural, H., Chauleur, C., Hafid, J., Raberin, H. & Tran Manh Sung, R. ( 2008; ). A technique for dating toxoplasmosis in pregnancy and comparison with the VIDAS anti-toxoplasma IgG avidity test. Clin Microbiol Infect 14, 242–249.[CrossRef]
    [Google Scholar]
  8. Hedman, K. & Seppälä, I. ( 1988; ). Recent rubella virus infection indicated by a low avidity of specific IgG. J Clin Immunol 8, 214–221.[CrossRef]
    [Google Scholar]
  9. Hedman, K., Lappalainen, M., Seppälä, I. & Mäkelä, O. ( 1989; ). Recent primary toxoplasma infection indicated by a low avidity of specific IgG. J Infect Dis 159, 736–740.[CrossRef]
    [Google Scholar]
  10. Hedman, K., Lappalainen, M., Söderlund, M. & Hedman, L. ( 1993; ). Avidity of IgG in serodiagnosis of infectious diseases. Rev Med Microbiol 4, 123–129.[CrossRef]
    [Google Scholar]
  11. Horvath, K. N., Szenasi, Z., Danka, J. & Kucsera, I. ( 2005; ). Value of the IgG avidity in the diagnosis of recent toxoplasmosis: a comparative study of four commercially available anti-Toxoplasma gondii IgG avidity assays. Acta Parasitol 50, 255–260.
    [Google Scholar]
  12. Jenum, P. A., Stray-Pedersen, B. & Gundersen, A. G. ( 1997; ). Improved diagnosis of primary Toxoplasma gondii infection in early pregnancy by determination of antitoxoplasma immunoglobulin G avidity. J Clin Microbiol 35, 1972–1977.
    [Google Scholar]
  13. Landis, J. R. & Koch, G. G. ( 1977; ). The measurement of observer agreement for categorical data. Biometrics 33, 159–174.[CrossRef]
    [Google Scholar]
  14. Lappalainen, M., Koskela, P., Koskiniemi, M., Ammälä, P., Hiilesmaa, V., Teramo, K., Raivio, K. O., Remington, J. S. & Hedman, K. ( 1993; ). Toxoplasmosis acquired during pregnancy: improved serodiagnosis based on avidity of IgG. J Infect Dis 167, 691–697.[CrossRef]
    [Google Scholar]
  15. Lefevre-Pettazzoni, M., Le Cam, S., Wallon, M. & Peyron, F. ( 2006; ). Delayed maturation of immunoglobulin G avidity: implication for the diagnosis of toxoplasmosis in pregnant women. Eur J Clin Microbiol Infect Dis 25, 687–693.[CrossRef]
    [Google Scholar]
  16. Liesenfeld, O., Montoya, J. G., Kinney, S., Press, C. & Remington, J. S. ( 2001; ). Effect of testing for IgG avidity in the diagnosis of Toxoplasma gondii infection in pregnant women: experience in a US reference laboratory. J Infect Dis 183, 1248–1253.[CrossRef]
    [Google Scholar]
  17. Logar, J., Novak-Antolic, Z. & Zore, A. ( 1999; ). Specific IgG avidity – a supplementary assay in serological screening for toxoplasmosis in pregnancy. J Infect 38, 61–63.[CrossRef]
    [Google Scholar]
  18. Montoya, J. G. & Remington, J. S. ( 1995; ). Studies on the serodiagnosis of toxoplasmic lymphadenitis. Clin Infect Dis 20, 781–789.[CrossRef]
    [Google Scholar]
  19. Montoya, J. G., Huffman, H. B. & Remington, J. S. ( 2004; ). Evaluation of the immunoglobulin G avidity test for diagnosis of toxoplasmic lymphadenopathy. J Clin Microbiol 42, 4627–4631.[CrossRef]
    [Google Scholar]
  20. Petersen, E. ( 2007; ). Toxoplasmosis. Semin Fetal Neonatal Med 12, 214–223.[CrossRef]
    [Google Scholar]
  21. Petersen, E., Borobio, M. V., Guy, E., Liesenfeld, O., Meroni, V., Naessens, A., Spranzi, E. & Thulliez, P. ( 2005; ). European multicenter study of the LIAISON automated diagnostic system for determination of Toxoplasma gondii-specific immunoglobulin G (IgG) and IgM and the IgG avidity index. J Clin Microbiol 43, 1570–1574.[CrossRef]
    [Google Scholar]
  22. Remington, J. S., Thulliez, P. & Montoya, J. G. ( 2004; ). Recent developments for diagnosis of toxoplasmosis. J Clin Microbiol 42, 941–945.[CrossRef]
    [Google Scholar]
  23. Soula, F., Fréalle, E., Durand-Joly, I., Dutoit, E., Rouland, V., Renard, E., Houfflin-Debarge, V., Subtil, D., Camus, D. & other authors ( 2007; ). Intérêt de l'indice d'avidité des IgG pour le diagnostic d'exclusion d'une toxoplasmose récente: comparaison de la trousse Toxo IgG Avidité SFRI® à la trousse Toxo IgG Avidity VIDAS®. Ann Biol Clin (Paris) 65, 257–264.
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.006668-0
Loading
/content/journal/jmm/10.1099/jmm.0.006668-0
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error